神经元BST2与PAR2在IL-27驱动瘙痒通路中的作用
该研究探讨IL-27在慢性瘙痒中的作用,利用转基因小鼠、瘙痒模型及RNA测序发现AD皮肤中IL-27受体过表达,IL-27不直接致痒但上调PAR2并增强PAR2介导的瘙痒,同时促进感觉神经元和角质形成细胞表达BST2,神经元特异性敲除BST2减轻痒反应。
要点
- IL-27不直接致痒,但通过上调PAR2增强其介导的瘙痒。
- IL-27促进感觉神经元和角质形成细胞表达BST2,BST2注射可致痒。
- 感觉神经元特异性敲除BST2减轻小鼠痒反应。
核心结论
- 皮肤IL-27/PAR2轴与神经元IL-27/BST2轴参与皮肤炎症和瘙痒。
- 神经元BST2是瘙痒级联中的新介质。
研究设计与样本
- 使用组织特异性转基因小鼠、多种瘙痒模型、行为评分、RNA测序及细胞因子/激酶阵列。
主要发现
- 人AD皮肤中IL-27受体过表达。
- 小鼠皮内注射IL-27不直接诱发瘙痒,但上调皮肤PAR2转录本。
- IL-27激活人角质形成细胞,增加PAR2转录和活性。
- 小鼠共注射SLIGRL与IL-27增强PAR2介导的瘙痒。
- IL-27促进感觉神经元和角质形成细胞中BST2转录,AD皮肤中BST2上调,注射BST2诱导痒样反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic itch is a common and complex symptom often associated with skin diseases such as atopic dermatitis (AD). Although IL-27 is linked to AD, its role and clinical significance in itch remain undefined. We sought to investigate IL-27 function in itch using tissue-specific transgenic mice, various itch models, behavior scoring, RNA sequencing, and cytokine/kinase array. Our findings show that IL-27 receptors were overexpressed in human AD skin. Intradermal IL-27 injection failed to directly induce itch in mice but upregulated skin protease-activated receptor 2 (PAR2) transcripts, a key factor in itch and AD. IL-27 activated human keratinocytes, increasing PAR2 transcription and activity. Coinjection of SLIGRL (PAR2 agonist) and IL-27 in mice heightened PAR2-mediated itch. In addition, IL-27 boosted BST2 transcription in sensory neurons and keratinocytes. BST2 was upregulated in AD skin, and its injection in mice induced itch-like response. BST2 colocalized with sensory nerve branches in AD skin from both human and murine models. Sensory neurons released BST2, and mice with sensory neuron-specific BST2 knockout displayed reduced itch responses. Overall, this study provides evidence that skin IL-27/PAR2 and neuronal IL-27/BST2 axes are implicated in cutaneous inflammation and pruritus. The discovery of neuronal BST2 in pruritus shed light on BST2 in the itch cascade.
引用
- Li Y, Chen W, Zhu X, et al. Neuronal BST2: A Pruritic Mediator alongside Protease-Activated Receptor 2 in the IL-27-Driven Itch Pathway. J Invest Dermatol. 2024. PMID: 38360199. doi:10.1016/j.jid.2024.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。